The EMEA ‘s Committee for Human Medicinal Products has assessed the application and issued a positive opinion will European Commission , which generally follows, but is not required to follow, and the recommendation of the CHMP announces final marketing approval within two to three months information drugs . Once the the EC, a single license would be to Pharmion to market thalidomide for first-line multiple myeloma granted in the 27 Member States of the European Union plus Norway and Iceland. – We are very pleased with this recommendation by the EMEA recognize us for the approval of thalidomide in the treatment of first-line multiple myeloma, and the return the return of thalidomide therapy approved in Europe as a safe a significant step towards this distribution is important and widely used drug for patients with multiple myeloma, said Patrick J. Mahaffy, Pharmion president and chief executive officer. That was a long and complex process, and all all the participants in the dialogue that led to close this recommendation the EMEA, the European thalidomide groups, patient organizations, the hematology community and the employees of Pharmion, this did happening. We were will continue will continue for the administration of thalidomide with the respect that its history requires. .
The authors further recommend that a simple nutrition labeling should be more detailed back-of-pack labeling, such as supplemented Guideline Daily Amounts. Gerda Feunekes adds, ‘to help, and not confuse the consumer, it is important a multitude of different a multitude of different labeling formats Consequently, such a label should be sector-and even cross-country. ‘. – ‘Front-of-pack labels may provide a powerful tool for consumers, Therefore, the options, ‘health behavior expert says Hans Brug, professor at the VU University Medical Centre in Amsterdam. ‘A simple logo as the Choices stamp provides an interpretation of the overall health of a food or drink, so little room for misinterpretation by consumers. For more complex systems, such as traffic lights or Guideline Daily Amounts, consumers still need to weigh the information provided. ‘.
Replikins Ltd. Has determined that very high concentrations of Replikin gene sequences of in Trypanosoma, the the causative agent of malaria, Used. Find to levels in society, in fact, the highest Replikin concentrations have watched in all infectious disease agent informed. The enterprise also noted that these concentrations cycle of over several years.
Few years Over the last 10 malarial world did accounting to over 10 millions of deaths – in comparison during the same period which H5N1 virus responsible for less than 300 human fatalities. Found in in accordance with the high level Replikin include in the study trypanosomes have some of the highest replicating Show Prices in the countryside. This characteristic can part make up for the resistance by malarial to earlier attempts on inoculation. Discovering the relationships the replikins fast replication offers a new approach, and the means to prevent rapid replication and mortality in the malaria.